{"id":1670,"date":"2021-08-10T12:36:56","date_gmt":"2021-08-10T12:36:56","guid":{"rendered":"https:\/\/challengeseconomiques.com\/?p=1670"},"modified":"2021-08-10T12:37:12","modified_gmt":"2021-08-10T12:37:12","slug":"covid-19-les-grandes-firmes-pharmaceutiques-realisent-des-chiffres-impressionnants","status":"publish","type":"post","link":"https:\/\/challengeseconomiques.com\/?p=1670","title":{"rendered":"COVID 19, les grandes firmes pharmaceutiques r\u00e9alisent des chiffres impressionnants"},"content":{"rendered":"<p>Le groupe Pfizer alli\u00e9 au laboratoire Bion Tech a annonc\u00e9 une augmentation de 92% de son chiffre d&rsquo;affaires trimestriel par rapport \u00e0 l&rsquo;ann\u00e9e pr\u00e9c\u00e9dente, atteignant 18,9 milliards de dollars d\u2019apr\u00e8s le site d\u2019information RT. Le site indique \u00e9galement que son b\u00e9n\u00e9fice net trimestriel a augment\u00e9 de 59%. Ces r\u00e9sultats pour le moins impressionnants montrent clairement que les affaires marchent bien pour les firmes pharmaceutiques en cette p\u00e9riode de pand\u00e9mie, o\u00f9 toutes les \u00e9conomies ont eu recours \u00e0 la perfusion pour r\u00e9sister \u00e0 la charge.<\/p>\n<p>En ce moment, la seule solution qui se pr\u00e9sente en effet \u00e0 tous les pays, y compris les grandes puissances, c\u2019est le vaccin. Et face \u00e0 l\u2019apparition de variant comme \u00ab&nbsp;Delta&nbsp;\u00bb la situation se complique davantage pour les chefs de file de la riposte. Tous les pays se battent pour vacciner leur population afin de ne pas replonger dans une nouvelle crise \u00e9conomique.<\/p>\n<p>Aux Etats unis, le maire de la ville de New offre m\u00eame, la somme de 100 dollars \u00e0 tout citoyen qui accepte de se faire vacciner. En France et dans certains autres pays occidentaux, la trouvaille, c\u2019est le pass sanitaire. Il faut se faire vacciner pour pouvoir acc\u00e9der \u00e0 certains endroits. Dans les pays ne disposant de ressources importantes, on se serre la ceinture. Et, par le biais d\u2019arbitrages budg\u00e9taires, on essaie de &nbsp;trouver l\u2019argent n\u00e9cessaire, pour acheter des vaccins C\u2019est le cas au S\u00e9n\u00e9gal. Il y a \u00e9galement les initiatives comme Covax et celle de l&nbsp;\u2019Union africaine. Toutes ces actions militent en faveur de la vaccination donc au b\u00e9n\u00e9fice de ces firmes pharmaceutiques lesquelles r\u00e9alisent des chiffres qui affolent les compteurs.<\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Le groupe Pfizer alli\u00e9 au laboratoire Bion Tech a annonc\u00e9 une augmentation de 92% de son chiffre d&rsquo;affaires trimestriel par rapport \u00e0 l&rsquo;ann\u00e9e pr\u00e9c\u00e9dente, atteignant&#8230;<\/p>\n","protected":false},"author":3,"featured_media":1671,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[23,10],"tags":[],"class_list":["post-1670","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-a-la-une","category-infos-eco","wpcat-23-id","wpcat-10-id"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.1.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>COVID 19, les grandes firmes pharmaceutiques r\u00e9alisent des chiffres impressionnants - challenges economiques<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/challengeseconomiques.com\/?p=1670\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"COVID 19, les grandes firmes pharmaceutiques r\u00e9alisent des chiffres impressionnants - challenges economiques\" \/>\n<meta property=\"og:description\" content=\"Le groupe Pfizer alli\u00e9 au laboratoire Bion Tech a annonc\u00e9 une augmentation de 92% de son chiffre d&rsquo;affaires trimestriel par rapport \u00e0 l&rsquo;ann\u00e9e pr\u00e9c\u00e9dente, atteignant...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/challengeseconomiques.com\/?p=1670\" \/>\n<meta property=\"og:site_name\" content=\"challenges economiques\" \/>\n<meta property=\"article:published_time\" content=\"2021-08-10T12:36:56+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-08-10T12:37:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/challengeseconomiques.com\/wp-content\/uploads\/2021\/08\/Pfizer2.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"924\" \/>\n\t<meta property=\"og:image:height\" content=\"616\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"aliou kane ndiaye\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"aliou kane ndiaye\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/challengeseconomiques.com\/?p=1670#article\",\"isPartOf\":{\"@id\":\"https:\/\/challengeseconomiques.com\/?p=1670\"},\"author\":{\"name\":\"aliou kane ndiaye\",\"@id\":\"https:\/\/challengeseconomiques.com\/#\/schema\/person\/2f70a31e102db1741c1a1c00c2bbd8a6\"},\"headline\":\"COVID 19, les grandes firmes pharmaceutiques r\u00e9alisent des chiffres impressionnants\",\"datePublished\":\"2021-08-10T12:36:56+00:00\",\"dateModified\":\"2021-08-10T12:37:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/challengeseconomiques.com\/?p=1670\"},\"wordCount\":304,\"image\":{\"@id\":\"https:\/\/challengeseconomiques.com\/?p=1670#primaryimage\"},\"thumbnailUrl\":\"https:\/\/challengeseconomiques.com\/wp-content\/uploads\/2021\/08\/Pfizer2.jpg\",\"articleSection\":[\"A la une\",\"Infos \u00e9co\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/challengeseconomiques.com\/?p=1670\",\"url\":\"https:\/\/challengeseconomiques.com\/?p=1670\",\"name\":\"COVID 19, les grandes firmes pharmaceutiques r\u00e9alisent des chiffres impressionnants - challenges economiques\",\"isPartOf\":{\"@id\":\"https:\/\/challengeseconomiques.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/challengeseconomiques.com\/?p=1670#primaryimage\"},\"image\":{\"@id\":\"https:\/\/challengeseconomiques.com\/?p=1670#primaryimage\"},\"thumbnailUrl\":\"https:\/\/challengeseconomiques.com\/wp-content\/uploads\/2021\/08\/Pfizer2.jpg\",\"datePublished\":\"2021-08-10T12:36:56+00:00\",\"dateModified\":\"2021-08-10T12:37:12+00:00\",\"author\":{\"@id\":\"https:\/\/challengeseconomiques.com\/#\/schema\/person\/2f70a31e102db1741c1a1c00c2bbd8a6\"},\"breadcrumb\":{\"@id\":\"https:\/\/challengeseconomiques.com\/?p=1670#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/challengeseconomiques.com\/?p=1670\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/challengeseconomiques.com\/?p=1670#primaryimage\",\"url\":\"https:\/\/challengeseconomiques.com\/wp-content\/uploads\/2021\/08\/Pfizer2.jpg\",\"contentUrl\":\"https:\/\/challengeseconomiques.com\/wp-content\/uploads\/2021\/08\/Pfizer2.jpg\",\"width\":924,\"height\":616},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/challengeseconomiques.com\/?p=1670#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/challengeseconomiques.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"COVID 19, les grandes firmes pharmaceutiques r\u00e9alisent des chiffres impressionnants\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/challengeseconomiques.com\/#website\",\"url\":\"https:\/\/challengeseconomiques.com\/\",\"name\":\"challenges economiques\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/challengeseconomiques.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/challengeseconomiques.com\/#\/schema\/person\/2f70a31e102db1741c1a1c00c2bbd8a6\",\"name\":\"aliou kane ndiaye\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/challengeseconomiques.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/df942321e58711a9f1fee838e446766660477bacd4b42fa20400d2c7cf4da7ca?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/df942321e58711a9f1fee838e446766660477bacd4b42fa20400d2c7cf4da7ca?s=96&d=mm&r=g\",\"caption\":\"aliou kane ndiaye\"},\"sameAs\":[\"http:\/\/www.challengeseconomiques.com\"],\"url\":\"https:\/\/challengeseconomiques.com\/?author=3\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"COVID 19, les grandes firmes pharmaceutiques r\u00e9alisent des chiffres impressionnants - challenges economiques","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/challengeseconomiques.com\/?p=1670","og_locale":"fr_FR","og_type":"article","og_title":"COVID 19, les grandes firmes pharmaceutiques r\u00e9alisent des chiffres impressionnants - challenges economiques","og_description":"Le groupe Pfizer alli\u00e9 au laboratoire Bion Tech a annonc\u00e9 une augmentation de 92% de son chiffre d&rsquo;affaires trimestriel par rapport \u00e0 l&rsquo;ann\u00e9e pr\u00e9c\u00e9dente, atteignant...","og_url":"https:\/\/challengeseconomiques.com\/?p=1670","og_site_name":"challenges economiques","article_published_time":"2021-08-10T12:36:56+00:00","article_modified_time":"2021-08-10T12:37:12+00:00","og_image":[{"width":924,"height":616,"url":"https:\/\/challengeseconomiques.com\/wp-content\/uploads\/2021\/08\/Pfizer2.jpg","type":"image\/jpeg"}],"author":"aliou kane ndiaye","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"aliou kane ndiaye","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/challengeseconomiques.com\/?p=1670#article","isPartOf":{"@id":"https:\/\/challengeseconomiques.com\/?p=1670"},"author":{"name":"aliou kane ndiaye","@id":"https:\/\/challengeseconomiques.com\/#\/schema\/person\/2f70a31e102db1741c1a1c00c2bbd8a6"},"headline":"COVID 19, les grandes firmes pharmaceutiques r\u00e9alisent des chiffres impressionnants","datePublished":"2021-08-10T12:36:56+00:00","dateModified":"2021-08-10T12:37:12+00:00","mainEntityOfPage":{"@id":"https:\/\/challengeseconomiques.com\/?p=1670"},"wordCount":304,"image":{"@id":"https:\/\/challengeseconomiques.com\/?p=1670#primaryimage"},"thumbnailUrl":"https:\/\/challengeseconomiques.com\/wp-content\/uploads\/2021\/08\/Pfizer2.jpg","articleSection":["A la une","Infos \u00e9co"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/challengeseconomiques.com\/?p=1670","url":"https:\/\/challengeseconomiques.com\/?p=1670","name":"COVID 19, les grandes firmes pharmaceutiques r\u00e9alisent des chiffres impressionnants - challenges economiques","isPartOf":{"@id":"https:\/\/challengeseconomiques.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/challengeseconomiques.com\/?p=1670#primaryimage"},"image":{"@id":"https:\/\/challengeseconomiques.com\/?p=1670#primaryimage"},"thumbnailUrl":"https:\/\/challengeseconomiques.com\/wp-content\/uploads\/2021\/08\/Pfizer2.jpg","datePublished":"2021-08-10T12:36:56+00:00","dateModified":"2021-08-10T12:37:12+00:00","author":{"@id":"https:\/\/challengeseconomiques.com\/#\/schema\/person\/2f70a31e102db1741c1a1c00c2bbd8a6"},"breadcrumb":{"@id":"https:\/\/challengeseconomiques.com\/?p=1670#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/challengeseconomiques.com\/?p=1670"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/challengeseconomiques.com\/?p=1670#primaryimage","url":"https:\/\/challengeseconomiques.com\/wp-content\/uploads\/2021\/08\/Pfizer2.jpg","contentUrl":"https:\/\/challengeseconomiques.com\/wp-content\/uploads\/2021\/08\/Pfizer2.jpg","width":924,"height":616},{"@type":"BreadcrumbList","@id":"https:\/\/challengeseconomiques.com\/?p=1670#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/challengeseconomiques.com\/"},{"@type":"ListItem","position":2,"name":"COVID 19, les grandes firmes pharmaceutiques r\u00e9alisent des chiffres impressionnants"}]},{"@type":"WebSite","@id":"https:\/\/challengeseconomiques.com\/#website","url":"https:\/\/challengeseconomiques.com\/","name":"challenges economiques","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/challengeseconomiques.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/challengeseconomiques.com\/#\/schema\/person\/2f70a31e102db1741c1a1c00c2bbd8a6","name":"aliou kane ndiaye","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/challengeseconomiques.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/df942321e58711a9f1fee838e446766660477bacd4b42fa20400d2c7cf4da7ca?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/df942321e58711a9f1fee838e446766660477bacd4b42fa20400d2c7cf4da7ca?s=96&d=mm&r=g","caption":"aliou kane ndiaye"},"sameAs":["http:\/\/www.challengeseconomiques.com"],"url":"https:\/\/challengeseconomiques.com\/?author=3"}]}},"jetpack_featured_media_url":"https:\/\/challengeseconomiques.com\/wp-content\/uploads\/2021\/08\/Pfizer2.jpg","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/challengeseconomiques.com\/index.php?rest_route=\/wp\/v2\/posts\/1670","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/challengeseconomiques.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/challengeseconomiques.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/challengeseconomiques.com\/index.php?rest_route=\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/challengeseconomiques.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=1670"}],"version-history":[{"count":2,"href":"https:\/\/challengeseconomiques.com\/index.php?rest_route=\/wp\/v2\/posts\/1670\/revisions"}],"predecessor-version":[{"id":1673,"href":"https:\/\/challengeseconomiques.com\/index.php?rest_route=\/wp\/v2\/posts\/1670\/revisions\/1673"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/challengeseconomiques.com\/index.php?rest_route=\/wp\/v2\/media\/1671"}],"wp:attachment":[{"href":"https:\/\/challengeseconomiques.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=1670"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/challengeseconomiques.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=1670"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/challengeseconomiques.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=1670"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}